Posts Tagged ‘product development’

View from the floor 4: Risk aversion in cell therapy development

Author: Paul Krzyzanowski, 05/04/12

  Commercialization plenary summary: part 3 of 4 On day two (May 1) of the Till and McCulloch Meetings, Dr. Emily Culme-Seymour from the London Regenerative Medicine Network introduced work that leverages previous clinical trial information to support future cell therapy efforts. In an analysis of almost 3000 clinical trials extracted from, Culme-Seymour focused on cell therapy related trials….Read more